Immunomedics (IMMU) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.20 | -1.84 | -1.45 | -0.37 | 1.58 | 2.69 | |||
| Changes by years, y/y, % | -68% | -253% | -21% | -74% | -524% | -15.8% | |||
Immunomedics. Debt/EBITDA
Immunomedics. Debt/EBITDA, changes, %
Immunomedics (IMMU) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2017Q4 | FY2018Q1 | FY2018Q2 | FY2020Q1 | FY2020Q2 | LTM ? | |||
| Debt/EBITDA | 0.18 | 0.54 | 1.58 | 1.27 | 2.69 | 2.69 | ||
| Changes by years, y/y, % | -113% | -178% | -524% | |||||
| Changes by quarters, q/q, % | +93% | +198% | +192% | -20% | +112% | |||